about
Immunosuppressive regimens for liver transplantation: a network meta-analysisManagement of immunosuppressant agents following liver transplantation: Less is moreNeoplastic disease after liver transplantation: Focus on de novo neoplasmsStrategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantationIncidence, risk factors and outcome of de novo tumors in liver transplant recipients focusing on alcoholic cirrhosisEfficient generation of hepatic cells from mesenchymal stromal cells by an innovative bio-microfluidic cell culture device.Betel quid chewing leads to the development of unique de novo malignancies in liver transplant recipients, a retrospective single center study in Taiwan.Liver transplant patients have a risk of progression similar to that of sporadic patients with branch duct intraductal papillary mucinous neoplasms.Hepatocellular carcinoma: Surgeon's view on latest findings and future perspectives.Review on immunosuppression in liver transplantation.Immunosuppression and Multiple Primary Malignancies in Kidney-Transplanted Patients: A Single-Institute StudyInsulin-Like Growth Factor I (IGF-I) Expressed from an AAV1 Vector Leads to a Complete Reversion of Liver Cirrhosis in Rats.Maintenance of normal blood pressure is dependent on IP3R1-mediated regulation of eNOS.Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis.Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches.Efficacy and safety of basiliximab in liver transplantation for patients with hepatitis B virus-related diseases: a single centre study.Incidence and Risk Factors for Tuberculosis After Liver Transplantation in an Endemic Area: A Nationwide Population-Based Matched Cohort Study.Extensive multifocal branch duct IPMN of the pancreas after liver transplantation: is surgery justified?De-novo hepatocellular carcinoma after pediatric living donor liver transplantation.Influence of hepatorenal syndrome on outcome of living donor liver transplantation: A single-center experience in 357 patients.
P2860
Q24186842-15AB5752-212E-4240-A78B-BC230A5D9085Q26770033-97D7D09C-8746-4239-B89D-FD9827C4E0E6Q26798306-3AE6DD8D-CF9B-46E9-9A72-21F1E00564EFQ27005375-10B72790-B453-4830-8AFE-35E855835DF9Q27025406-56F53F42-2D5B-41BE-92EC-2C32A658C116Q27321782-220E0B20-2100-41AA-8ECE-902911BBD300Q33595456-BDD756C9-2F26-44ED-A70E-29E3D8C30D55Q35067692-AA21C567-2DCB-4008-BD05-30A2BF7DF614Q35626761-3E0ED7D0-B86A-435F-9D59-554534420A82Q35668757-122F9A20-A849-401C-B9C1-1F09049A1B79Q35818080-1F64AA75-5B3F-4642-A1DA-6D6D716B2C57Q36141134-BC859F17-DD3E-46FD-ADA1-8EEF671922E3Q37142664-E4CBC484-00A3-4A86-9232-3B0B3EBD7EBEQ38737314-C92839C6-FF4D-44A6-8E36-32D79AD50682Q39067623-044A73FD-6DA8-4372-B12B-6BCEAA75EF06Q40733984-DA1A5053-A8F8-41BF-9258-50DE9A202334Q41074978-2C40CC7A-2566-4757-ABC1-61BB62EC9697Q43201553-A7A9745A-4030-4715-A932-59036300F938Q47550111-021562CA-E7D9-44B0-BD43-E5C08F0C5AFDQ47765124-E3EC98EC-ACA1-47D8-9315-771D510EEB62
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Liver transplantation: immunosuppression and oncology
@ast
Liver transplantation: immunosuppression and oncology
@en
Liver transplantation: immunosuppression and oncology
@nl
type
label
Liver transplantation: immunosuppression and oncology
@ast
Liver transplantation: immunosuppression and oncology
@en
Liver transplantation: immunosuppression and oncology
@nl
prefLabel
Liver transplantation: immunosuppression and oncology
@ast
Liver transplantation: immunosuppression and oncology
@en
Liver transplantation: immunosuppression and oncology
@nl
P2860
P921
P3181
P1476
Liver transplantation: immunosuppression and oncology
@en
P2093
Manuel De la Mata
Manuel Rodríguez-Perálvarez
P2860
P304
P3181
P356
10.1097/MOT.0000000000000069
P407
P5008
P577
2014-06-01T00:00:00Z